Who We Are
Theranostics is an emerging branch in cancer treatment that uses a single agent for both diagnosis and therapy. Theranostics can seek out cancer, reveal it under medical imaging and deliver treatment payloads locally at the cancer site. Combining these functions empowers the personalization of cancer medicine, such that treatments can be highly targeted and individualized. Treatments become intimately linked to imaging: the therapeutic effects can be directly monitored, and treatment plans can be adjusted immediately to maximize the benefits of treatment to patients.
At the University Health Network our multidisciplinary team of oncologists, radiologists, scientists and other research staff work together to translate new theranostic agents from the lab to the clinic.
World Class Resources
At University Health Network (UHN), the Princess Margaret Cancer Centre (Princess Margaret), the Techna Institute for the Advancement of Technology for Health (Techna) and the Joint Department of Medical Imaging (JDMI) have leading imaging programs with world-class infrastructure and resources.